Judit Oldekamp, Cornelia Eichner 2009 Elecsys Testosterone II Technical Performance of Elecsys Testosterone II
Testosterone Background I Current immunoassays for testosterone seem to over-estimate testosterone in the female matrix. The effect is variable and cannot be predicted for any given sample: Inaccurate calibration or interference by cross-reacting substances is almost certainly the cause of the problem, but for many immunoassays, the exact nature of the interferent is not known 1. A second generation Elecsys Testosterone II immunoassay was developed to improve the recovery of testosterone if compared to Isotope Dilution Gas Chromatography/Mass Spectrometry (ID-GC/MS) reference method. Elecsys Testosterone II uses a new high affinity sheep monoclonal testosterone antibody: Significantly reduced matrix effects and reduced interference by cross-reacting substances. 1 Kane et al 2007, Measurement of serum Testosterone in women, what should we do?, Clinical Biochem; 44: 5-15 2
Testosterone Background II The new assay shows a significant improved accuracy in female samples. In addition, cross-reactivity to Dehydroepiandrosterone sulphate (DHEAS) is reduced. The assay demonstrates a good correlation with liquid chromatography tandem mass spectrometry (LC-MS/MS) and provides excellent imprecision and functional sensitivity data. Average value of female testosterone samples (in line with LC-MS/MS) shows approx. 30% negative bias if compared to current Elecsys Testosterone immunoassays. On the other hand, there is no significant change in male testosterone values. 3
Testosterone General I The androgen testosterone (17 -hydroxyandrostenone) has a molecular weight of 288 Daltons. Most of the circulating testosterone is bound to the carrier proteins (SHBG = sex hormone-binding globulin) and albumin. Testosterone 4
Testosterone General II - men In men, testosterone is synthesized almost exclusively by the Leydig cells of the testes. The secretion of testosterone is regulated by luteinizing hormone (LH), and is subject to negative feedback via the pituitary and hypothalamus. Testosterone promotes the development of the secondary sex characteristics in men and serves to maintain the function of the prostate and seminal vesicles. Testosterone is determined in men when reduced testosterone production is suspected, e.g. in hypogonadism, estrogen therapy, chromosome aberrations (as in the Klinefelter s syndrome) and liver cirrhosis. 5
Testosterone General III - women In women, small quantities of testosterone are formed in the ovaries from adrenal precursors. In physiological concentrations, androgens appear to be necessary to induce libido in women. Increased production of testosterone in women can cause virilization (depending on the increase of the Testosterone level). The determination of testosterone in women is helpful in the diagnosis of andrenogenital syndrome (AGS), polycystic ovaries (Stein-Leventhal syndrome) and when an ovarian tumor, adrenal tumor, adrenal hyperplasia or ovarian insufficiency is suspected. 6
Elecsys Testosterone II Reagents I Reagent rackpack (ready for use) M Streptavidin-coated microparticles (transparent cap) R1 biotinylated monoclonal anti-testosterone antibody (sheep), (gray cap) R2 Testosterone-peptide ~ Ru (black cap). Testosterone derivative, labeled with ruthenium complex 7
Elecsys Testosterone II Reagents II Calibrators (lyophilisate) Cal 1 Testosterone calibrator 1 (white cap), 2 bottles (lyophilized) for 1.0 ml Cal 2 Testosterone calibrator 2 (black cap), 2 bottles (lyophilized) for 1.0 ml PreciControl Universal (lyophilisate) PCU 1 Testosterone control, 2 bottles (lyophilized) for each 1.0 ml PCU 2 Testosterone control, 2 bottles (lyophilized) for each 1.0 ml 8
Elecsys Testosterone II - Reagent handling Reagent rackpack (ready for use) Calibrators: Dissolve carefully by adding exactly 1.0 ml of distilled water, Mix carefully, avoid formation of foam. Reconstitute for 15 min. Transfer aliquots of the calibrators into empty labeled snap-cap bottles (CalSet Vials). Attach the supplied labels. Store immediately at -20 C. Controls: Dissolve carefully by adding exactly 1.0 ml of distilled water, Mix carefully, avoid formation of foam. Reconstitute for 15 min. Transfer aliquots of the controls into appropriate vials. Store immediately at 20 C. Calibrators and Controls: Perform only one calibration or control procedure per aliquot. Stability at -20 C: 4 weeks (freeze only once). 9
Elecsys Testosterone II - Test principle I Competition principle. Total duration of assay: 18 minutes. 1st incubation: 20 μl of sample are incubated with a biotinylated high affinity monoclonal testosterone-specific antibody (sheep). The binding sites of the labeled antibody become occupied by the sample analyte (depending on its concentration). 2nd incubation: Streptavidin-coated microparticles and a testosterone derivative labeled with a ruthenium complex are added. Still free binding sites are occupied by the labeled conjugate. The entire complex becomes bound to the solid phase via interaction of biotin and streptavidin. Measurement: The reaction mixture is aspirated into the measuring cell where the microparticles are magnetically captured onto the surface of the electrode. Unbound substances are then removed with ProCell. Application of a voltage to the electrode then induces chemiluminescent emission which is measured by a photomultiplier. 10
Elecsys Testosterone II - Test principle II Competition format 11
Elecsys Testosterone II Typical master standard curve Signal is reciprocally proportional to analyte concentration Elecsys Testosterone II Calibration Curve r E2010 MP-Kit 04.06.2009 08:54:23 RPZMS000579/TESTO_II/FH0024 Protokoll Id: -Draft- OLDEKAMJ Vers.:5.3.4 5 2.5x10 Competitive standard curve 2.0x10 5 5 1.5x10 5 1.0x10 Data source: Elecsys Testosterone II Assay development FH0024 MP-Kit 4 5.0x10 0 0 5 10 15 [ng/ml] Testosterone 12
Elecsys Testosterone II Traceability I Standardized against ID-GC/MS (female and male samples) - the assay shows a very good correlation to ID-GC/MS 18 16 14 Elecsys Testosterone II [ng/ml] 12 10 8 6 4 2 0 Points x=y BaPa LinReg 0 2 4 6 8 10 12 14 16 18 ID - GC/MS [ng/ml] 13 Number of samples measured: 39 total (19 male and 20 female samples) The sample concentrations were between approx. 0.173 and 17.3 ng/ml. Data Source: Elecsys Testosterone II Ref Stand MP Kit Elecsys 2010
Elecsys Testosterone II Traceability II Standardized against ID-GC/MS (female samples) the assay shows a very good correlation to ID-GC/MS in female samples 2.5 2 Elecsys Testosterone II [ng/ml] 1.5 1 Number of samples measured: 20 The sample concentrations were between approx. 0.173 and 2.29 ng/ml. 0.5 0 Points x=y BaPa LinReg 0 0.5 1 1.5 2 2.5 ID - GC/MS [ng/ml] 14 Data Source: Elecsys Testosterone II Ref Stand MP Kit Elecsys 2010
Elecsys Testosterone II Comparison to LC-MS/MS I High correlation to the LC-MS/MS method (female samples from clinical routine, ARUP, USA) Method Comparision Testo II vs. LC-MS/MS r Testo II vs. LC-MS/MS 04.06.2009 10:49:15 RPZMS000579/TESTO7/EV_324 Protokoll Id: -Draft- OLDEKAMJ Vers.:5.3.4 [ng/ml] 4 Elecsys Testosterone II 3 2 Anzahl Wertepaare: 171 P/B y = 0.0297 + 0.9333*x (Kendalls tau)= 0.7752) LinRegYX y = 0.0446 + 0.9232*x (Pearsons r)= 0.9808) W.Halb y = x 1 0 0 1 2 3 4 [ng/ml] LC-MS/MS Data Source: Elecsys Testosterone II Ev_324 Research Kit 15
Elecsys Testosterone II Comparison to LC-MS/MS II Ratio plots confirm the improved results in accuracy of female samples withtesto II if compared to LC-MS/MS Ratio plots 1 and 2: Comparison of Elecsys Testo I and Testo II with LC-MS/MS (Roche internal method) using UK-NEQAS female and male ring trial samples (UK NEQAS Distr. 334-343, 345-348; 33 females and 40 male samples; no spiked serum samples). The x-axis (in ng/ml) represents the testosterone concentration measured by LC-MS/MS; the y-axis represents the immunoassay testosterone concentration divided by the LC-MS/MS testosterone concentration. Ratio of 1 means: the two methods gave the same result. 2,5 2,0 Ratio Plot 1 Testosterone I 2,5 2,0 Ratio Plot 2 Testosterone II new Testo I / LC-MSMS 1,5 1,0 Testo II/LC-MSMS 1,5 1,0 0,5 0,5 0,0 0,00 1,00 2,00 3,00 4,00 5,00 6,00 7,00 8,00 9,00 LC-MS/MS 0,0 0,00 1,00 2,00 3,00 4,00 5,00 6,00 7,00 8,00 9,00 LC-MS/MS 16
Elecsys Testosterone II Method Comparison II Comparison of routine samples with Elecsys Testosterone I and II An approx.30% negative bias in female samples can be expected with Testo II compared to Testo I, male samples are highly similar with both methods A Methodcomparison Testo II vs. Testo I Method Comparison Testo I vs. Testo II Testo II vs. Testo I, Lab Limbach Heidelberg 22.04.2009 12:39:40 RPZMS000579/TESTO_II/ROTH2008 Protokoll Id: -Draft- OLDEKAMJ Vers.:5.3.4 ng/ml r B Methodcomparison Testo II vs. Testo I Method Comparison Testo I vs. Testo II Testo II vs. Testo I, Lab Limbach Heidelberg 22.04.2009 12:57:57 RPZMS000579/TESTO_II/ROTH2008 Protokoll Id: -Draft- OLDEKAMJ Vers.:5.3.4 ng/ml r C Methodcomparison Testo II vs. Testo I Method Comparison Testo I vs. Testo II Testo II vs. Testo I, Lab Limbach Heidelberg 22.04.2009 12: 49:10 RPZMS000579/TESTO_II/ROTH2008 Protokoll Id: -Draft- OLDEKAMJ Vers.:5.3.4 ng/ml r 1.4 15 1.2 2.0 1.0 1.5 Testo II 10 Testo II 0.8 Testo II 0.6 1.0 5 0.4 0.2 0.5 0 0 5 10 15 ng/ml Testo I 0 0 0.2 0.4 0.6 0.8 1.0 1.2 1.4 ng/ml Testo I 0 0 0.5 1.0 1.5 2.0 ng/ml Testo I - - - - - - Anzahl Wertepaare: 1291 P/B y =-0.0300 + 1.0000*x (Kendalls tau)= 0.8940) LinRegYX y =-0.0809 + 1.0216*x (Pearsons r)= 0.9812) W.Halb y = x All samples (males and females) Frauen female dialysis DialysepatientIn Männer male Anzahl Wertepaare: 1291 Section of picture A; P/B concentration of sera: LinRegYX W.Halb 1.6 ng/ml y =-0.0300 + 1.0000*x (Kendalls tau)= 0.8940) y =-0.0809 + 1.0216*x (Pearsons r)= 0.9812) y = x female Frauen dialysis DialysepatientIn Männer male Anzahl Wertepaare: 448 P/B y = 0.0665 + 0.6154*x (Kendalls tau)= 0.7439) LinRegYX y = 0.0608 + 0.6403*x (Pearsons r)= 0.8973) W.Halb y = x Female samples only female Frauen dialysis Dialysepatientin 17 Routine clinical samples from Labor Limbach, Heidelberg
Elecsys Testosterone II- Method Comparison I Method comparison E170 vs. Elecsys 2010 - shows an excellent correlation between both platforms Plot_MC 18.0 16.0 14.0 Elecsys Testosterone II 2010 12.0 10.0 8.0 6.0 4.0 P/B Regression Y = 1.004 * X - 0.001 2.0 md(95) = 0.063 N = 40 r = 1.0000 t = 0.9974 0.0 0.0 2.0 4.0 6.0 8.0 10.0 12.0 14.0 16.0 18.0 Elecsys Testosterone II E170 Data source: Elecsys Testosterone II Standardization D031/09 P03 kit 18
Elecsys Testosterone II Multicenter Evaluation Data very good repeatability and intermediate precision over the whole measuring range on Elecsys 2010 cobas e 411 Elecsys 2010 and cobas e 411 analyzers Repeatability a Intermediate Precision b Sample Mean SD CV SD CV ng/ml nmol/l ng/ml nmol/l % ng/ml nmol/l % Human Serum 1 0.095 0.330 0.004 0.014 4.7 0.008 0.028 8.4 Human Serum 2 0.691 2.40 0.014 0.048 2.1 0.022 0.076 3.2 Human Serum 3 2.16 7.50 0.042 0.146 1.9 0.060 0.208 2.8 Human Serum 4 8.67 30.1 0.229 0.795 2.6 0.243 0.843 2.8 Human Serum 5 13.0 45.1 0.158 0.548 1.2 0.440 1.53 3.4 PreciControl U1 6.30 21.9 0.088 0.305 1..4 0.182 0.632 2.9 PreciControl U2 2.65 9.20 0.047 0.163 1.8 0.097 0.337 3.7 Data source: Elecsys Testosterone II MCE study MP kit CLSI EP5-A2 a) Repeatability = within-run precision b) Intermediate precision = total precision 19
Elecsys Testosterone II Precision II Multicenter Evaluation Data - very good repeatability and intermediate precision over the whole measuring range on Modular Analytics E170 and cobas e 601 MODULAR ANALYTICS E170 and cobas e 601 analyzers Repeatability Intermediate precision Sample Mean SD CV SD CV ng/ml nmol/l ng/ml nmol/l % ng/ml nmol/l % Human Serum 1 0.091 0.316 0.014 0.049 14.8 0.017 0.059 18.1 Human Serum 2 0.696 2.42 0.029 0.097 4.1 0.030 0.104 4.4 Human Serum 3 2.13 7.39 0.059 0.017 2.8 0.067 0.232 3.2 Human Serum 4 8.79 2.53 0.236 0.833 2.7 0.292 1.01 3.3 Human Serum 5 13.1 45.8 0.281 0.081 2.1 0.331 1.15 2.5 PreciControl U1 6.08 21.1 0.179 0.625 2.9 0.190 0.659 3.1 PreciControl U2 2.56 8.88 0.066 0.229 2.6 0.093 0.323 3.6 Data source: Elecsys Testosterone II MCE study MP kit Precision CLSI EP5-A2. a) Repeatability = within-run precision b) Intermediate precision = total precision 20
Elecsys Testosterone II - Precision III Multicenter Evaluation Data very good repeatability over the whole measuring range - comparable to Testosterone I or even better Repeatability Data (n=21) MCE Elecsys Testosterone II 12 10 8 CV [%] 6 4 2 0 0 2 4 6 8 10 12 14 16 Mean Values Testosterone [ng/ml] Testo e 411 Testo e 170 Testo II e 411 Testo II e 170 21
Elecsys Testosterone II Precision IV Multicenter Evaluation Data very good intermediate over the whole measuring range - comparable to Testosterone I or even better Within - Laboratory ("Total") Precision Data (MCE Elecsys Testosterone II, 21 Days, 2 Runs per Day, 2 Replicates) 20,0 16,0 CV [%] 12,0 8,0 4,0 0,0 0 2 4 6 8 10 12 14 16 Mean Values Testosterone [ng/ml] Testo e411 Testo II e411 Testo E170 Testo II E170 22
Elecsys Testosterone II Limit of Quantitation Application Report Data Limit of Quantitation (LoQ or Functional Sensitivity) very good precision in the lower range on 2010/ cobas e 411 and E170/cobas e 601 Functional Sensitivity (LoQ) Elecsys Testosterone II for 2010 30.0 25.0 CV [%] 20.0 15.0 10.0 5.0 0.0 0.00 0.05 0.10 0.15 0.20 0.25 0.30 Concentration [ng/ml] LOQ: ~8% CV at 0,12 ng/ml LoB: 0.012 ng/ml; LoD: 0.025 23
Elecsys Testosterone II Cross-Reactivity Accuracy of results not compromised by cross-reactive substances Concentration (ng/ml) Cross reactivity % Androstendione 100 2.5 10 ng/ml Danazol 1000 0.5 1 ug/ml DHEA-S 50000 0.003 20 ug/ml D-5-Androstene-3β,17β-diol 1000 0.29 unknown Estradiol 1000 0.16 30 ng/ml Ethisterone 1000 2.40 unknown Norgestrel 1000 0.91 2 ng/ml Testosterone propionate 100 2.46 unknown 5-α-Androstane-3β,17β-diol 1000 2.11 unknown 5-α-Dihydrotestosterone 500 0.87 1,5 ng/ml 11-β-Hydroxytestosterone 100 18.0 unknown 11-keto-Testosterone 1000 3.22 1 ng/ml Prednisone 1000 n.d. 1 ug/ml Prednisolone 1000 0.002 1 ug/ml Progesterone 1000 n.d. 40 ng/ml Cortisol 1000 0.01 550 ng/ml Cortisone 2000 n.d. 550 ng/ml Dexamethasone 2000 n.d. unknown Estrone 1000 0.004 500 pg/ml DHEA 1000 0.016 15 ng/ml n.d.: not detectable 24 Known physiological highest concentration Data source: Application report data MP kit
Elecsys Testosterone Expected Values I in package insert lot 154749-01, expiry date 07/2010 Results obtained with the Elecsys Testosterone II assay in an apparently healthy group of 214 males and 190 females without intake of contraceptiva and prescription drugs (MCE study number CIM 000669) Percentiles Males (20-50y) Males (> 50y) Females (21-50y) Females (> 50y) N Median 5-95 th 2.5-97.5 th Median 5-95 th 2.5-97.5 th ng/ml nmol/l 137 5.36 2.50-8.36 2.18-9.05 18.6 8.69-29.0 7.58-31.4 77 4.76 1.93-7.44 1.32-8.99 16.5 6.68-25.8 4.57-31.2 105 0.248 0.058-0.476 0.035-0.513 0.860 0.200-1.65 0.120-1.78 85 0.170 0.026-0.432 < 0.025-0.520 0.590 0.090-1.50 < 0.087-1.79 25
Elecsys Testosterone Expected Values IIa - update Testosterone panel in combination with SHBG Data, package insert will be updated with these new data with next Testosterone lot. Results obtained with the Elecsys Testosterone II assay in an apparently healthy group of 214 males and 160 females without intake of contraceptiva and prescription drugs (MCE study number CIM 000669) Percentiles Test subjects N Median 5-95th 2.5-97th Median 5-95th 2.5-97th ng/ml nmol/l Males 20-49 years Males > 50 years Females 20-49 years Females > 50 years 136 5.36 2.49-8.36 2.18-9.06 18.6 8.64-29.0 7.57-31.4 78 4.76 1.93-7.40 1.32-8.92 16.5 6.68-25.7 4.59-31.0 89 0.271 0.084-0.481 0.050-0.522 0.941 0.290-1.67 0.173-1.81 71 0.162 0.029-0.408 < 0.025-0.461 0.563 0.101-1.42 0.070-1.60 26
Elecsys Testosterone Expected Values IIb - update Testosterone panel - SHBG Data Results were evaluated with focus on Testosterone II assay included measurements in parallel with the Elecsys SHBG assay (MCE study number CIM 000669). SHBG Percentiles Test subjects N Median 5-95th nmol/ml 2.5-97.5th Males 20-49 years Males > 50 years Females 20-49 years Females > 50 years 136 78 89 71 33.5 16.5-55.9 15.4-63.8 40.8 19.3-76.4 14.2-78.0 64.3 24.6-122 19.1-145 57.4 17.3-125 14.4-136 27
Elecsys Testosterone Expected Values IIc - update Testosterone panel Free Testosterone index (FTI) of free androgen index (FAI) Results were evaluated with focus on Testosterone II assay included measurements in parallel with the Elecsys SHBG assay (MCE study number CIM 000669) and commonly used parameters derived from different calculation procedures, including albumin as an important parameter involved.* Percentiles Test subjects N Median 5-95th FTI or FAI (%) 2.5-97.5th Males 20-49 years Males > 50 years Females 20-49 years Females > 50 years 136 57.2 78 38.2 89 1.53 71 1.15 35.0-92.6 24.0-104 24.3-72.1 21.6-77.1 0.297-5.62 0.178-7.07 0.187-3.63 0.104-4.95 * Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999;84:3666-3672. 28
Elecsys Testosterone Expected Values IId - update Testosterone panel Free Testosterone, calculated Results were evaluated with focus on Testosterone II assay included measurements in parallel with the Elecsys SHBG assay (MCE study number CIM 000669) and commonly used parameters derived from different calculation procedures, including albumin as an important parameter involved.* Percentiles Test subjects N Median 5-95th 2.5-97.5th Median FTc (nmol/l) FTc (%) 5-95th 2.5-97.5th Males 20-49 years Males > 50 years Females 20-49 years Females > 50 years 136 78 89 71 0.379 0.198-0.619 0.174-0.672 2.10 1.53-2.88 1.47-2.97 0.304 0.163-0.473 0.129-0.567 1.91 1.23-2.59 1.16-2.81 0.011 0.003-0.33 0.001-0.034 1.19 0.701-2.19 0.601-2.36 0.008 0.001-0.020 0.001-0.022 1.26 0.685-2.64 0.632-2.80 * Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999;84:3666-3672. 29
Elecsys Testosterone Expected Values IIe - update Testosterone panel Bioavailable Testosterone, calculated Results were evaluated with focus on Testosterone II assay included measurements in parallel with the Elecsys SHBG assay (MCE study number CIM 000669) and commonly used parameters derived from different calculation procedures, including albumin as an important parameter involved.* Percentiles Test subjects N Median 5-95th 2.5-97.5th Median BATc (nmol/l) BATc (%) 5-95th 2.5-97.5th Males 20-49 years Males > 50 years Females 20-49 years Females > 50 years 136 78 89 71 9.10 4.36-14.3 3.68-15.3 49.8 35.0-66.3 31.7-68.2 6.63 3.59-11.0 3.07-12.6 42.1 27.5-60.7 24.2-63.7 0.246 0.059-0.756 0.033-0.774 25.7 15.3-47.7 13.0-56.1 0.168 0.030-0.430 <0.025-0.460 28.0 15.1-55.2 14.3-59.8 * Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999;84:3666-3672. 30
Elecsys Testosterone II Expected values IIe - update Distribution of testosterone values in the apparently healthy male control group dependent on age, n = 214. Solid line: 50% percentile, upper line: 97.5% percentile, lower line 2.5% percentile 31
Elecsys Testosterone II Expected values IIf - update Distribution of testosterone values in the apparently healthy female control group dependent on age, n = 160. Solid line: 50% percentile, upper line: 97.5% percentile, lower line 2.5% percentile 32
Elecsys Testosterone II Competitor Comparison Comparison of Elecsys Testosterone with Bayer Centaur good correlation in male samples, in female samples a positive bias of around 20% with an intercept of 0.23 can be expected with Bayer Centaur when comparing to Elecsys Testo II Plot_MC 16 1,8 14 1,6 12 1,4 TESTO_Siem Chemiluminescence ng/ml Centaur 10 8 6 TESTO_Siem Chemiluminescence ng/ml Centaur 1,2 1 0,8 0,6 4 0,4 P/B Regression 2 Y = 1.022 * X + 0.235 md(95) = 1.297 N = 152 r = 0.9735 t = 0.8766 0 0 2 4 6 8 10 12 14 16 TESTO_2 ECLIA ng/ml SWA E170 P/B Regression Y = 1.206 * X + 0.23 0,2 md(95) = 0.148 N = 110 r = 0.8763 t = 0.6871 0 0 0,2 0,4 0,6 0,8 1 1,2 1,4 1,6 1,8 TESTO_2 ECLIA ng/ml SWA E170 Males 33 Females
Elecsys Testosterone II Competitor Comparison Comparison of Elecsys Testosterone with ABBOTT AxSym - good correlation in male samples and female samples Plot_MC 16 2,5 14 12 2 TESTO_Abb MEIA ng/ml Abbott AxSym 10 8 6 TESTO_Abb MEIA ng/ml Abbott AxSym 1,5 1 4 2 0 0 2 4 6 8 10 12 14 16 TESTO_2 ECLIA ng/ml SWA E170 P/B Regression Y = 0.972 * X + 0.022 md(95) = 1.104 N = 152 r = 0.9783 t = 0.8964 0,5 P/B Regression Y = 0.983 * X + 0.039 md(95) = 0.178 N = 110 r = 0.7713 t = 0.6561 0 0 0,5 1 1,5 2 2,5 TESTO_2 ECLIA ng/ml SWA E170 Males 34 Females
Elecsys Testosterone II Competitor Comparison Comparison of Elecsys Testosterone with Beckman Access - good correlation in male samples, in female samples a positive bias of around 23% with an intercept of 0.15 can be expected with Beckman Access when comparing to Elecsys Testo II Plot_MC 18 2,5 16 14 2 TESTO_BeCo Chemiluminescence ng/ml Beckm.Access 12 10 8 6 TESTO_BeCo Chemiluminescence ng/ml Beckm.Access 1,5 1 4 0,5 2 0 0 2 4 6 8 10 12 14 16 18 TESTO_2 ECLIA ng/ml SWA E170 P/B Regression Y = 1.016 * X + 0.148 md(95) = 1.081 N = 152 r = 0.9832 t = 0.9065 P/B Regression Y = 1.231 * X + 0.148 md(95) = 0.147 N = 110 r = 0.8881 t = 0.7681 0 0 0,5 1 1,5 2 2,5 TESTO_2 ECLIA ng/ml SWA E170 Males 35 Females
Elecsys Testosterone II Competitor Comparison Comparison of Elecsys Testosterone with Siemens Immulite 2000 - good correlation in male samples, in female samples a positive bias of around 30% with an intercept of - 0.05 can be expected with Siemens Immulite when comparing to Elecsys Testo II Plot_MC 16 1,6 14 1,4 TESTO_Siem Chemiluminescence ng/ml IMMULITE 2000 Siemens 12 10 8 6 4 TESTO_Siem Chemiluminescence ng/ml IMMULITE 2000 Siemens 1,2 1 0,8 0,6 0,4 2 0 0 2 4 6 8 10 12 14 16 TESTO_2 ECLIA ng/ml SWA E170 P/B Regression Y = 0.915 * X + 0.164 md(95) = 1.424 N = 135 r = 0.9624 t = 0.8510 P/B Regression 0,2 Y = 1.305 * X - 0.045 md(95) = 0.156 N = 70 r = 0.8454 t = 0.6507 0 0 0,2 0,4 0,6 0,8 1 1,2 1,4 1,6 TESTO_2 ECLIA ng/ml SWA E170 Males 36 Females
Elecsys Testosterone II Competitor Comparison Comparison of Elecsys Testosterone with DPC RIA - good correlation in male samples, in female samples a fairly good correlation can be expected with DPC RIA when comparing to Elecsys Testo II Plot_MC 16 2 14 1,8 12 1,6 1,4 TESTO_Siem RIA ng/ml DPC RIA 10 8 6 TESTO_Siem RIA ng/ml DPC RIA 1,2 1 0,8 0,6 4 2 0 0 2 4 6 8 10 12 14 16 TESTO_2 ECLIA ng/ml SWA E170 P/B Regression Y = 1.03 * X + 0.186 md(95) = 1.158 N = 152 r = 0.9768 t = 0.8817 0,4 P/B Regression Y = 1.131 * X - 0.012 0,2 md(95) = 0.219 N = 107 r = 0.8446 t = 0.6774 0 0 0,2 0,4 0,6 0,8 1 1,2 1,4 1,6 1,8 2 TESTO_2 ECLIA ng/ml SWA E170 Males 37 Females
Elecsys Testosterone II - Key Performance Overview Total Duration Assay Principle Sample Volume LOB LOD LOQ Measuring range Traceability Total precision Sample material Reagent stability Onboard stability Dilution Expected values 18 Minutes Competitive 20 μl < 0.012 ng/ml < 0.025 ng/ml < 0.12 ng/ml 0.025 (= LOD) 15 ng/ml ID-GC/MS targeted female and male testosterone samples CV% 2.2 8.5% (0.22-13.18 ng/ml), MCE CIM000669 Serum and plasma (Li-heparin; K2- and K3-EDTA plasma) Unopened at 2 8 C up to the stated expiration date 8 weeks on all analyzers Generally not necessary due to the broad measuring range Please refer to the page 20-22 for the details. 38